Tag Archives: Poseida Therapeutics

Roche to Acquire Poseida Therapeutics, Advancing Leadership in Cell Therapy Innovation

Posted on 27, November 2024 by

(IN BRIEF) Roche has announced the acquisition of Poseida Therapeutics, a clinical-stage biopharmaceutical company specializing in off-the-shelf CAR-T cell therapies, for $9.00 per share in cash, totaling approximately $1 billion. Poseida stockholders may also receive up to $4.00 per share … Read the full press release →

Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology

Tagged , , , , , , , , ,